Veeva Systems Inc. (Veeva) is a provider of cloud-based software solutions for the global life sciences industry. The Company's industry cloud for life sciences consists of the solution sets: Veeva CRM, its core customer relationship management solution and related solutions; Veeva Vault, its regulated content management and collaboration solutions; Veeva Network, its customer master data management solution, and Veeva OpenKey, its data and related services offerings. It provides updates to its software solutions three times per year. Updates are included in its subscription and are not subject to an additional fee. Upgrades are implemented by Veeva in its cloud computing environment such that when a new update is put into production, the prior version is replaced. Veeva OpenKey customer data is available in Australia, China, France, Italy, the United Kingdom and the United States.
Forbes Ranks Veeva Fourth Fastest Growing Public Tech Company 7:03 am ET May 3, 2016 (BusinessWire) Print Veeva Systems (NYSE: VEEV), a leading provider of industry cloud solutions for life sciences, was named among the top fastest growing public technology companies on Forbes' annual Fast Tech 25 list. Veeva's average sales growth of 47% over the past three fiscal years ranked it fourth among companies on this year's list. Veeva's ranking signifies the growing importance of industry cloud - a new breed of specialized cloud solutions that are tailored to meet the needs of a particular industry. According to Gartner, industry-specific software is the largest segment of the enterprise software market. For years, many industries have been stuck on aging industry-specific client/server or custom solutions and unable to transition some of their most crucial business processes to the cloud. Veeva was founded in 2007 on the premise that industry cloud would be the next wave of cloud computing and pioneered industry cloud solutions for the life sciences industry. "Our tremendous growth has been fueled by the innovation we've brought to the cloud technology market and our commitment to customer success," said Peter Gassner, Veeva founder and CEO. "We're honored to be among the most trusted providers to one of the largest global industries in their mission to improve and extend life." Veeva's industry cloud solutions are specifically designed to help life sciences companies achieve their most pressing strategic objectives in bringing drugs to market faster and more efficiently, marketing and selling them more effectively, and maintaining compliance with government regulations. Veeva's growing base of 400 customers relies on Veeva's industry cloud solutions to address a broad range of business requirements in the life sciences industry. Each year Forbes ranks the 25 fastest-growing technology companies based on their three-year average sales growth rates. Forbes evaluated more than 5,000 public traded technology companies, looking for profitable companies with a minimum revenue of $150 million and a minimum market value of $500 million. Forbes then looked for firms with sales growth of at least 10% for each of the past three fiscal years and over the latest 12 months to compile its final rankings.
Reported after close today (5/26/16) Earnings: EPS $0.15 Revenue $119.8M Estimates: EPS $0.11 Revenue $115M Up 9.19% after hours so far
Shares of Veeva Systems Inc. VEEV surged 5.2% in afterhours trading following the company’s impressive second-quarter fiscal 2017 results. Veeva reported adjusted earnings of 15 cents per share (considering stock-based compensation as a regular expense) in the quarter, a 20.9% increase on a year-over-year basis. The Zacks Consensus Estimate for the second quarter earnings stands at 8 cents per share. The year-over-year earnings upside was primarily driven by a strong 34% surge in revenues, which totaled $131 million, well ahead of the Zacks Consensus Estimate of $125 million.
VEEV looks more than ready. I'll probably be getting in on Monday. My $1-box by 3-box-reversal point and figure objective is $105.
Legged into VEEV. Note the general lack of volatility and declining volume through the trading range is indicative of a re-accumulation trading range. Bot here on the back up to the creek, which so far is not showing significant supply. Daily: